Summary
Intel Corporation's first quarter of 2009 filing (ending March 27, 2009) reveals a significant year-over-year decline in net revenue, down 26% to $7.145 billion from $9.673 billion in Q1 2008. This downturn is attributed to the weak global economy, reduced PC demand, and inventory corrections within the supply chain. Consequently, net income also saw a substantial drop, with diluted earnings per share falling to $0.11 from $0.25 in the prior year quarter. Despite the revenue challenges, Intel has focused on operational adjustments, including reducing headcount and streamlining manufacturing operations. The company also highlights its continued investment in research and development, particularly in its 32nm process technology, and its strategic focus on platform solutions and energy-efficient performance. The company also declared a quarterly dividend of $0.14 per share.
Financial Highlights
27 data points| Revenue | $7.14B |
| Cost of Revenue | $3.91B |
| Gross Profit | $3.24B |
| R&D Expenses | $1.32B |
| SG&A Expenses | $1.20B |
| Operating Expenses | $2.59B |
| Operating Income | $647.00M |
| Net Income | $629.00M |
| EPS (Basic) | $0.11 |
| EPS (Diluted) | $0.11 |
| Shares Outstanding (Basic) | 5.57B |
| Shares Outstanding (Diluted) | 5.63B |
Key Highlights
- 1Net revenue declined by 26% year-over-year to $7.145 billion, reflecting a challenging macroeconomic environment.
- 2Diluted earnings per share decreased to $0.11 from $0.25 in the same period last year.
- 3Gross margin percentage fell to 45.3% from 53.8% year-over-year, impacted by factory underutilization and new process technology start-up costs.
- 4Operating expenses saw a reduction, with R&D spending down 10% and MG&A expenses down 11% year-over-year.
- 5The company announced restructuring plans involving closing assembly and test facilities and stopping production at certain wafer fabrication facilities.
- 6Intel continued its investment in new technologies, including the 32nm process technology, positioning for future market recovery.
- 7The company maintained a strong balance sheet, with cash and cash equivalents totaling $3.536 billion.